scispace - formally typeset
E

Erica Spackman

Researcher at United States Department of Agriculture

Publications -  158
Citations -  8651

Erica Spackman is an academic researcher from United States Department of Agriculture. The author has contributed to research in topics: Influenza A virus subtype H5N1 & Virus. The author has an hindex of 45, co-authored 154 publications receiving 7877 citations. Previous affiliations of Erica Spackman include University of Georgia & University of Minnesota.

Papers
More filters
Journal ArticleDOI

Optimizing Surveillance for South American Origin Influenza A Viruses Along the United States Gulf Coast Through Genomic Characterization of Isolates from Blue‐winged Teal (Anas discors)

TL;DR: In this article, the authors genomically characterized 45 viruses isolated from blue-winged teal (Anas discors) along the Texas and Louisiana Gulf Coast during March of 2012 and 2013, coincident with northward migration of this species from Neotropical wintering areas to breeding grounds in the United States and Canada.
Journal ArticleDOI

Do crocodilians get the flu? Looking for influenza A in captive crocodilians

TL;DR: Viable virus could not be recovered from RT‐PCR‐positive samples, although this is consistent with previous attempts at viral isolation in embryonated chicken eggs with crocodilian viruses.
Journal ArticleDOI

Improving risk assessment of the emergence of novel influenza A viruses by incorporating environmental surveillance.

TL;DR: Coupling quantitative disease models and natural transmission studies with new molecular technologies, such as deep-mutational scanning and single-virus sequencing of environmental samples, should dramatically improve the understanding of viral co-occurrence and reassortment.
Journal ArticleDOI

Cross-Protection by Inactivated H5 Prepandemic Vaccine Seed Strains against Diverse Goose/Guangdong Lineage H5N1 Highly Pathogenic Avian Influenza Viruses.

TL;DR: Virus diversity, immune response complexity, and the importance of strain selection for vaccine development to control H5N1 HPAIV in the agricultural sector and for human prepandemic preparedness are highlighted and the engineering of specific antigenic sites can improve the immunogenicity of H5 vaccines are suggested.